BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 32810364)

  • 1. Mitochondrial dysfunction and drug targets in multiple myeloma.
    Cui Y; Wang F; Fang B
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):8007-8016. PubMed ID: 36928159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NUPR1 is a critical repressor of ferroptosis.
    Liu J; Song X; Kuang F; Zhang Q; Xie Y; Kang R; Kroemer G; Tang D
    Nat Commun; 2021 Jan; 12(1):647. PubMed ID: 33510144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing of antipsychotic trifluoperazine for treating brain metastasis, lung metastasis and bone metastasis of melanoma by disrupting autophagy flux.
    Xia Y; Xu F; Xiong M; Yang H; Lin W; Xie Y; Xi H; Xue Q; Ye T; Yu L
    Pharmacol Res; 2021 Jan; 163():105295. PubMed ID: 33176207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-637 promotes apoptosis and suppresses proliferation and autophagy in multiple myeloma cell lines via NUPR1.
    Chen X; Li A; Zhan Q; Jing Z; Chen Y; Chen J
    FEBS Open Bio; 2021 Feb; 11(2):519-528. PubMed ID: 33332746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear protein 1 imparts oncogenic potential and chemotherapeutic resistance in cancer.
    Murphy A; Costa M
    Cancer Lett; 2020 Dec; 494():132-141. PubMed ID: 32835767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GATA6 triggers fibroblast activation and tracheal fibrosis through the Wnt/β-catenin pathway.
    Li A; Gu L; Mu J; Li Y; Wang X; Jiang J; Bai Y; Yang M; He C; Xiao R; Liao J; Jin X; Xiao M; Xiao Y; Zhang X; Tan T; Peng M; Xu L; Guo S
    Cell Signal; 2023 May; 105():110593. PubMed ID: 36682592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NUPR1 contributes to radiation resistance by maintaining ROS homeostasis via AhR/CYP signal axis in hepatocellular carcinoma.
    Zhan Y; Zhang Z; Liu Y; Fang Y; Xie Y; Zheng Y; Li G; Liang L; Ding Y
    BMC Med; 2022 Oct; 20(1):365. PubMed ID: 36258210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of Inhibitors of the Intrinsically Disordered Protein NUPR1: Balance between Drug Affinity and Target Function.
    Rizzuti B; Lan W; Santofimia-Castaño P; Zhou Z; Velázquez-Campoy A; Abián O; Peng L; Neira JL; Xia Y; Iovanna JL
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional coregualtor NUPR1 maintains tamoxifen resistance in breast cancer cells.
    Wang L; Sun J; Yin Y; Sun Y; Ma J; Zhou R; Chang X; Li D; Yao Z; Tian S; Zhang K; Liu Z; Ma Z
    Cell Death Dis; 2021 Feb; 12(2):149. PubMed ID: 33542201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p38 Molecular Targeting for Next-Generation Multiple Myeloma Therapy.
    Morales-Martínez M; Vega MI
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy-related mechanisms for treatment of multiple myeloma.
    Kozalak G; Koşar A
    Cancer Drug Resist; 2023; 6():838-857. PubMed ID: 38239705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrimeprazine is a neuroprotective antiviral in JEV infection via adaptive ER stress and autophagy.
    Prajapat SK; Mishra L; Khera S; Owusu SD; Ahuja K; Sharma P; Choudhary E; Chhabra S; Kumar N; Singh R; Kaushal PS; Mahajan D; Banerjee A; Motiani RK; Vrati S; Kalia M
    EMBO Mol Med; 2024 Jan; 16(1):185-217. PubMed ID: 38177535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy and Apoptosis: Current Challenges of Treatment and Drug Resistance in Multiple Myeloma.
    Al-Odat OS; Guirguis DA; Schmalbach NK; Yao G; Budak-Alpdogan T; Jonnalagadda SC; Pandey MK
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockage of Autophagy Increases Timosaponin AIII-Induced Apoptosis of Glioma Cells In Vitro and In Vivo.
    Lee CC; Tsai JP; Lee HL; Chen YJ; Chen YS; Hsieh YH; Chen JC
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solamargine induces autophagy-mediated apoptosis and enhances bortezomib activity in multiple myeloma.
    Han Q; Bai H; Xu Y; Zhou M; Zhou H; Dong X; Chen B
    Clin Exp Pharmacol Physiol; 2022 Jun; 49(6):674-685. PubMed ID: 35294057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension.
    Grobs Y; Awada C; Lemay SE; Romanet C; Bourgeois A; Toro V; Nadeau V; Shimauchi K; Orcholski M; Breuils-Bonnet S; Tremblay E; Provencher S; Paulin R; Boucherat O; Bonnet S
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trifluoperazine induces cellular apoptosis by inhibiting autophagy and targeting NUPR1 in multiple myeloma.
    Li A; Chen X; Jing Z; Chen J
    FEBS Open Bio; 2020 Oct; 10(10):2097-2106. PubMed ID: 32810364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trifluoperazine Synergistically Potentiates Bortezomib-Induced Anti-Cancer Effect in Multiple Myeloma via Inhibiting P38 MAPK/NUPR1.
    Jing Z; Yu W; Li A; Chen X; Chen Y; Chen J
    Tohoku J Exp Med; 2022 Jul; 257(4):315-326. PubMed ID: 35644544
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.